Then Bergh, F., Kümpfel, T., Grasser, A., Rupprecht, R., Holsboer, F., & Trenkwalder, C. (2001). Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial. Journal of Clinical Endocrinology & Metabolism, 86, 1610-1615.